Has Murray Gordon received payments from drug or device companies?

Yes. Drug and device makers reported $576,138 in general payments to Murray Gordon across 694 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Murray Gordon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Murray Gordon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Murray Gordon

Endocrinology, Diabetes & Metabolism · Pittsburgh, PANPI 1366414468

Payments from drug & device makers

$576,138in general payments, 2019–2025

Across 694 payments — averaging $830.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corcept Therapeutics$159K
Sanofi US Services Inc.$117K
Eli Lilly$71K
Strongbridge US Inc.$37K
Takeda Pharmaceuticals U.S.A., Inc.$27K
AbbVie$26K
plus $140K from 40 others

$7,651in research payments, 2019–2025

Across 20 payments — averaging $382.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Chiasma, Inc.$4K
Corcept Therapeutics$2K
Amryt Pharma Holdings Ltd$2K
Eli Lilly$480

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corcept Therapeutics	155	$159,268
Sanofi US Services Inc.	61	$116,931
Eli Lilly	8	$70,838
Strongbridge US Inc.	9	$37,101
Takeda Pharmaceuticals U.S.A., Inc.	24	$26,677
AbbVie(2 entities)	40	$25,691
Novo Nordisk	138	$23,318
Amryt Pharma Holdings Ltd	8	$18,439
OPKO Pharmaceuticals, LLC	3	$17,552
Chiasma, Inc.	2	$16,640
Novo Nordisk AS	5	$9,868
Recordati_rare_diseases_inc.	23	$9,792
Pfizer	7	$9,756
Ascendis Pharma Endocrinology Inc	4	$6,081
Xeris Pharmaceuticals, Inc.	6	$5,126
GSK	1	$4,658
Lilly USA, LLC	23	$3,904
Novartis	4	$3,253
Shire North American Group Inc	2	$3,017
HRA Pharma RARE Diseases	1	$2,000
Ipsen Biopharmaceuticals, Inc	8	$1,887
Lexicon Pharmaceuticals, Inc.	1	$690
Amgen(2 entities)	24	$667
Sanofi-aventis U.S. LLC	10	$304
Chiesi USA, Inc.	1	$280
Antares Pharma, Inc.	17	$273
Bayer	14	$235
Dexcom, Inc.	16	$222
Sanofi	2	$200
Amarin Pharma, Inc.	10	$193
AstraZeneca(2 entities)	10	$176
Amneal Pharmaceuticals LLC	7	$164
IBSA Pharma Inc.	9	$153
Cequr Corporation	1	$136
EUSA Pharma (US) LLC	12	$135
Boehringer Ingelheim	6	$104
Ultragenyx Pharmaceutical Inc.	4	$71
Abbott	4	$66
Radius Health, Inc.	3	$65
Medtronic	3	$57
Valeritas, Inc.	1	$36
Ferring Pharmaceuticals Inc.	2	$33
Merck	2	$30
Sun Pharmaceutical Industries Inc.	1	$18
Clarus Therapeutics Inc.	1	$16
Nestle Healthcare Nutrition Inc.	1	$15

How this compares

$576,138 in reported general payments places this provider in the 95th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.

See all endocrinology, diabetes & metabolism providers in Pennsylvania →

Other endocrinology, diabetes & metabolism in Pittsburgh

Vijay BahlPittsburgh$998K
Erin KershawPittsburgh$804K
Swarna VarmaPittsburgh$520K
Sachin BahlPittsburgh$162K
Peter GrondziowskiPittsburgh$143K
Patricia BononiPittsburgh$107K
Frederico ToledoPittsburgh$92K
Esra Karslioglu FrenchPittsburgh$73K
Mona Al MukaddamPhiladelphia$3.9M
Serge JabbourPhiladelphia$3.1M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →